Xiao Ennian, Xia-Zhang Linna, Vulliémoz Nicolas R, Ferin Michel, Wardlaw Sharon L
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.
Endocrinology. 2003 May;144(5):1736-41. doi: 10.1210/en.2002-220013.
alpha-MSH antagonizes many of the immune and neuroendocrine effects induced by inflammatory cytokines. Studies have shown that alpha-MSH attenuates the stimulatory effect of IL-1 on the hypothalamic-pituitary-adrenal (HPA) axis and plays a physiological role in limiting the HPA response to IL-1. Recently an alpha-MSH antagonist, agouti-related protein (AGRP), has been identified in the hypothalamus, which stimulates food intake by antagonizing the effects of alpha-MSH at specific melanocortin receptors. It is unknown whether AGRP can also modulate neuroendocrine responses to inflammatory cytokines. We have therefore examined the effects of AGRP on the HPA axis and on prolactin (PRL) at baseline and in response to stimulation by IL-1 beta in nine ovariectomized rhesus monkeys. In the first study, the effects of intracerebroventricular (i.c.v) infusion of 20 microg (n = 6) and 50 micro g (n = 4) of human AGRP (83-132)-NH(2) were compared with icv saline infusion. There was a significant stimulatory effect of 20 microg AGRP on cortisol release over time (P < 0.001). The area under the hormone response curve (AUC) for cortisol increased by 29% after 20 microg AGRP vs. saline; the AUC for ACTH increased by 166% (P = 0.028); the AUC for PRL increased by 108% (P = 0.046). There was a significant stimulatory effect of 50 microg AGRP on ACTH (P < 0.001), cortisol (P < 0.001), and PRL (P < 0.001) release over time. The AUC for ACTH after 50 microg AGRP increased by 98%; the AUC for cortisol increased by 37%; the AUC for PRL increased by 161%. The effects of AGRP on ACTH, cortisol, and PRL release were prevented by alpha-MSH infusion. In the second study, animals received icv either 50 ng of human IL-1 beta or 20 microg of AGRP followed by 50 ng IL-1 beta. AGRP significantly enhanced the ACTH (P < 0.05) response to IL-1 beta. The peak ACTH response to IL-1 beta alone was 124 +/- 55 pg/ml vs. 430 +/- 198 pg/ml after IL-1 beta plus AGRP; the peak cortisol response was 70 +/- 8.2 microg/dl vs. 77 +/- 6.2 microg/dl, but this was not significantly different. In conclusion, AGRP stimulated ACTH, cortisol, and PRL release in the monkey and enhanced the ACTH response to IL-1 beta. These studies suggest that, in addition to its known orexigenic effects, AGRP may play a role in neuroendocrine regulation and specifically that AGRP may interact with alpha-MSH to modulate neuroendocrine responses to inflammation.
α-促黑素(α-MSH)可拮抗多种由炎性细胞因子诱导产生的免疫和神经内分泌效应。研究表明,α-MSH可减弱白细胞介素-1(IL-1)对下丘脑-垂体-肾上腺(HPA)轴的刺激作用,并在限制HPA对IL-1的反应中发挥生理作用。最近,一种α-MSH拮抗剂,即刺鼠相关蛋白(AGRP),已在下丘脑中被鉴定出来,它通过在特定的黑皮质素受体上拮抗α-MSH的作用来刺激食物摄入。目前尚不清楚AGRP是否也能调节对炎性细胞因子的神经内分泌反应。因此,我们研究了AGRP对9只去卵巢恒河猴在基线状态下以及对IL-1β刺激的反应中HPA轴和催乳素(PRL)的影响。在第一项研究中,将脑室内(i.c.v)注入20微克(n = 6)和50微克(n = 4)人AGRP(83-132)-NH₂的效果与注入生理盐水的效果进行了比较。20微克AGRP随时间推移对皮质醇释放有显著的刺激作用(P < 0.001)。与生理盐水相比,20微克AGRP作用后皮质醇的激素反应曲线下面积(AUC)增加了29%;促肾上腺皮质激素(ACTH)的AUC增加了166%(P = 0.028);PRL的AUC增加了108%(P = 0.046)。50微克AGRP随时间推移对ACTH(P < 0.001)、皮质醇(P < 0.001)和PRL(P < 0.001)的释放有显著的刺激作用。50微克AGRP作用后ACTH的AUC增加了98%;皮质醇的AUC增加了37%;PRL的AUC增加了161%。AGRP对ACTH、皮质醇和PRL释放的作用可被α-MSH注入所阻断。在第二项研究中,动物脑室内注入50纳克人IL-1β或20微克AGRP,随后再注入50纳克IL-1β。AGRP显著增强了对IL-1β的ACTH反应(P < 0.05)。单独对IL-1β的ACTH峰值反应为124±55皮克/毫升,而在IL-1β加AGRP后为430±198皮克/毫升;皮质醇峰值反应分别为70±8.2微克/分升和77±6.2微克/分升,但差异不显著。总之,AGRP刺激了猴体内ACTH、皮质醇和PRL的释放,并增强了对IL-1β的ACTH反应。这些研究表明,除了其已知的促食欲作用外,AGRP可能在神经内分泌调节中发挥作用,特别是AGRP可能与α-MSH相互作用以调节对炎症的神经内分泌反应。